Published in Nat Rev Urol on February 09, 2010
Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) | NCT00529386
Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS) (IC01) | NCT00124306
Diagnostic Challenges in IC (and Male CPPS) | NCT00672087
An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome | NCT00701311
NGF - the TrkA to successful pain treatment. J Pain Res (2012) 0.92
Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection. Toxins (Basel) (2015) 0.91
The efficacy of mirodenafil for chronic prostatitis/chronic pelvic pain syndrome in middle-aged males. World J Mens Health (2014) 0.76
Analgesic effects of oligonol, acupuncture and quantum light therapy on chronic nonbacterial prostatitis. Iran Red Crescent Med J (2015) 0.75
Evaluation of the protective effect of pentoxifylline on carrageenan-induced chronic non-bacterial prostatitis in rats. Inflammopharmacology (2017) 0.75
The effectiveness of long-needle acupuncture at acupoints BL30 and BL35 for CP/CPPS: a randomized controlled pilot study. BMC Complement Altern Med (2017) 0.75
NIH consensus definition and classification of prostatitis. JAMA (1999) 5.35
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol (2005) 2.48
Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med (2004) 2.46
Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med (2006) 2.38
Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med (1999) 2.30
The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem (2006) 2.13
Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol (2001) 1.96
Failures and successes of NMDA receptor antagonists: molecular basis for the use of open-channel blockers like memantine in the treatment of acute and chronic neurologic insults. NeuroRx (2004) 1.91
Pregabalin: its pharmacology and use in pain management. Anesth Analg (2007) 1.91
Gabapentin: pharmacology and its use in pain management. Anaesthesia (2002) 1.69
Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med (2001) 1.64
Sickness impact of chronic nonbacterial prostatitis and its correlates. J Urol (1996) 1.62
Neurourological insights into the etiology of genitourinary pain in men. J Urol (1999) 1.61
Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol (2005) 1.58
Painful myofascial trigger points and pain sites in men with chronic prostatitis/chronic pelvic pain syndrome. J Urol (2009) 1.54
A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol (2004) 1.52
Antidepressants and pain. Trends Pharmacol Sci (2006) 1.51
Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. Urology (2002) 1.46
Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol (2009) 1.45
Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology (2003) 1.44
Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J Urol (2008) 1.39
Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol (2001) 1.38
A case-control study of risk factors in men with chronic pelvic pain syndrome. BJU Int (2005) 1.28
Experimental autoimmune prostatitis induces chronic pelvic pain. Am J Physiol Regul Integr Comp Physiol (2008) 1.28
Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin? Am J Geriatr Pharmacother (2005) 1.26
Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study. BJU Int (2004) 1.26
Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy. Brain Res (1992) 1.23
Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers. Br J Anaesth (2007) 1.16
Antidepressants for the treatment of chronic pain. Drugs (2008) 1.14
Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum (1999) 1.11
Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology (2000) 1.11
NMDA receptors as targets for drug action in neuropathic pain. Eur J Pharmacol (2001) 1.10
Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int (2007) 1.10
Adrenocortical hormone abnormalities in men with chronic prostatitis/chronic pelvic pain syndrome. Urology (2008) 1.09
Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology (2002) 1.09
Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wien Klin Wochenschr (2005) 1.08
Gabapentin in the treatment of neuropathic pain. Palliat Med (2004) 1.08
Complementary and alternative medicine for chronic prostatitis/chronic pelvic pain syndrome. Evid Based Complement Alternat Med (2005) 1.08
The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type III. Eur Urol (2005) 1.04
Genetics and phenotyping of urological chronic pelvic pain syndrome. J Urol (2009) 1.03
Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activity. Chem Biol (2009) 1.03
Chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: are they related? Curr Urol Rep (2006) 1.02
Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology (2004) 1.02
Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component. Prostate Cancer Prostatic Dis (2002) 0.99
Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16-19 years. BJU Int (2008) 0.99
Pregabalin: a review of its use in fibromyalgia. Drugs (2008) 0.98
Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol (2008) 0.97
A case of familial clustering of interstitial cystitis and chronic pelvic pain syndrome. Urology (2001) 0.94
Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. J Pain (2005) 0.94
Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J Urol (2007) 0.94
Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol (2005) 0.93
Amitriptyline modulation of Na(+) channels in rat dorsal root ganglion neurons. Eur J Pharmacol (2000) 0.93
Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biol Psychiatry (2007) 0.92
Cooled transurethral microwave thermotherapy for intractable chronic prostatitis--results of a pilot study after 1 year. Urology (2004) 0.91
Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials. Eur J Pain (2005) 0.91
Prostatitis: Infection, neuromuscular disorder, or pain syndrome? Proper patient classification is key. Cleve Clin J Med (2007) 0.90
Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology (2004) 0.90
Pregabalin in the treatment of chronic pain: an overview. Clin Drug Investig (2009) 0.89
Management of chronic prostatitis/chronic pelvic pain syndrome: an evidence-based approach. Urology (2006) 0.89
Memantine: a comprehensive review of safety and efficacy. Expert Opin Drug Saf (2009) 0.89
Opioids for chronic prostatitis and interstitial cystitis: lessons learned from the 11th World Congress on Pain. Urology (2006) 0.89
Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol (2006) 0.89
Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy. Neurosci Lett (1995) 0.89
Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: a preliminary report. Anesth Analg (2006) 0.88
Update on the use of memantine in Alzheimer's disease. Neuropsychiatr Dis Treat (2009) 0.87
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int (2007) 0.86
New therapy for neuropathic pain. Int Rev Neurobiol (2009) 0.86
Bladder training biofeedback and pelvic floor myalgia. Urology (2002) 0.86
NIDDK-sponsored chronic prostatitis collaborative research network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis. Int J Antimicrob Agents (2004) 0.81
Treatment of chronic prostatitis. Nat Clin Pract Urol (2004) 0.80
Chronic pelvic pain syndrome: a non-prostatocentric perspective. World J Urol (2003) 0.80
Opening the floodgates: benign prostatic hyperplasia may represent another disease in the compendium of ailments caused by the global sympathetic bias that emerges with aging. Med Hypotheses (2006) 0.79
[Corticoid combined with an antibiotic for chronic nonbacterial prostatitis]. Zhonghua Nan Ke Xue (2009) 0.78
[Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis]. Zhonghua Nan Ke Xue (2004) 0.77
Short course oral prednisolone therapy in chronic abacterial prostatitis and prostatodynia: case reports of three responders and one non-responder. Sex Transm Infect (2000) 0.77
Prostatitis: Clinical phenotyping of patients with pelvic pain. Nat Rev Urol (2009) 0.76
Chronic prostatitis/chronic pelvic pain syndrome in males may be an autoimmune disease, potentially responsive to corticosteroid therapy. Med Hypotheses (2008) 0.76
p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells. FEBS Lett (2007) 1.14
Drug delivery systems in urology--getting "smarter". Urology (2006) 0.81
Placental soluble fms-like tyrosine-kinase-1 (sFlt-1) in pregnant women with preeclampsia. Folia Med (Plovdiv) (2004) 0.79
Saw palmetto for benign prostatic hyperplasia. N Engl J Med (2006) 0.78
Effect of mycophenolate mofetil (Cell Cept) in the treatment of immune glomerulopathies. Folia Med (Plovdiv) (2004) 0.75
Ten-year clinical and ultrasonographic follow-up of siblings from families with autosomal dominant polycystic kidney disease. Folia Med (Plovdiv) (2002) 0.75